| P50 | author | Vuk Uskoković | Q37829335 |
| P2093 | author name string | Uskokovic V | |
| P2860 | cites work | Freeze-dried human serum albumin improves the adherence and proliferation of mesenchymal stem cells on mineralized human bone allografts | Q83527165 |
| | Tissue distribution of intravenously administrated hydroxyapatite nanoparticles labeled with 125I | Q83625161 |
| | The controlled release of vancomycin in gelatin/β-TCP composite scaffolds | Q83879862 |
| | Hydroxyapatite coating for titanium fibre mesh scaffold enhances osteoblast activity and bone tissue formation | Q83922470 |
| | Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress | Q83959005 |
| | Earlier debridement and antibiotic administration decrease infection | Q84009891 |
| | Primary tubercular osteomyelitis of the sternum | Q84067197 |
| | Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis | Q84151002 |
| | Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms | Q84175544 |
| | Antibiotic impregnated cement spacer for salvage of diabetic osteomyelitis | Q84460996 |
| | Paclitaxel delivery from cobalt-chromium alloy surfaces using self-assembled monolayers | Q84487062 |
| | Reorientation of thiols during 2D self-assembly: interplay between steric and energetic factors | Q84572512 |
| | Poly (ε-caprolactone) coating delays vancomycin delivery from porous chitosan/β-tricalcium phosphate composites | Q84583610 |
| | Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells | Q84588334 |
| | How can proteins enter the interior of a MOF? Investigation of cytochrome c translocation into a MOF consisting of mesoporous cages with microporous windows | Q84726619 |
| | Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties | Q84778502 |
| | Effect of phase composition and microstructure of calcium phosphate ceramic particles on protein adsorption | Q84784490 |
| | Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles | Q84838329 |
| | Histological evaluation at different times after augmentation of extraction sites grafted with a magnesium-enriched hydroxyapatite: double-blinded randomized controlled trial | Q85012798 |
| | Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery | Q85203612 |
| | Zinc-substituted hydroxyapatite: a biomaterial with enhanced bioactivity and antibacterial properties | Q85475113 |
| | Comparative study of different techniques for the sterilization of poly-L-lactide electrospun microfibers: effectiveness vs. material degradation. | Q43122387 |
| | Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release | Q43197764 |
| | Silver ions in the treatment of local infections | Q43203635 |
| | Controlled release properties and final macroporosity of a pectin microspheres-calcium phosphate composite bone cement | Q43237217 |
| | Management of chronic osteomyelitis in a developing country using ceftriaxone-PMMA beads: an initial study | Q43444216 |
| | Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis | Q43498239 |
| | A model for chronic osteomyelitis using Staphylococcus aureus in goats | Q43531377 |
| | Methyl methacrylate toxicity in rat nasal epithelium: studies of the mechanism of action and comparisons between species | Q43557514 |
| | Gentamicin-impregnated chitosan/nanohydroxyapatite/ethyl cellulose microspheres granules for chronic osteomyelitis therapy. | Q43639209 |
| | Preparation and compressive strength of alpha-tricalcium phosphate/gelatin gel composite cement. | Q43653760 |
| | Silica sol-gel for the controlled release of antibiotics. II. The effect of synthesis parameters on the in vitro release kinetics of vanomycin | Q43755222 |
| | Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis | Q43856389 |
| | Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute | Q43892203 |
| | Characterization of crosslinked high amylose starch matrix implants. 2. In vivo release of ciprofloxacin | Q44054853 |
| | Polymer--calcium phosphate cement composites for bone substitutes | Q44062465 |
| | Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis | Q44077360 |
| | Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis | Q44112743 |
| | Bone Mineralization during a Developing Zinc Deficiency | Q44127559 |
| | Antimicrobial release kinetics from polymethylmethacrylate in a novel continuous flow chamber | Q44164816 |
| | Development of a biodegradable alginate carrier system for antibiotics and bone cells. | Q44243158 |
| | A new bone-inducing biodegradable porous beta-tricalcium phosphate | Q44380026 |
| | Influence of surfactant molecules as air‐entraining agent for bone cement macroporosity | Q44432469 |
| | Dual-setting calcium phosphate cement modified with ammonium polyacrylate | Q44444314 |
| | Low-cost antibiotic loaded systems for developing countries | Q44459301 |
| | Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants | Q44557792 |
| | Osseous deformity from osteomyelitis variolosa. A case report | Q44602368 |
| | Phase evolution during the formation of stoichiometric hydroxyapatite at 37.4 °C | Q44607855 |
| | Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin | Q44611431 |
| | Foreign-body reactions to fracture fixation implants of biodegradable synthetic polymers | Q44678105 |
| | Manufacture of layered collagen/chitosan-polycaprolactone scaffolds with biomimetic microarchitecture | Q44689845 |
| | Osteomyelitis following Bacille Calmette-Guerin vaccination. | Q44700979 |
| | The use of antibiotic-containing bead chains in the treatment of chronic bone infections | Q44727487 |
| | Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity | Q44792791 |
| | Design and production of gentamicin/dextrans microparticles by supercritical assisted atomisation for the treatment of wound bacterial infections. | Q44806472 |
| | Use of gentamicin-loaded collagen sponge in internal fixation of open fractures | Q44824282 |
| | Properties and modification of porous 3-D collagen/hydroxyapatite composites. | Q44827861 |
| | Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis | Q44836060 |
| | Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo. | Q44910123 |
| | Heterogeneous structure and in vitro degradation behavior of wet-chemically derived nanocrystalline silicon-containing hydroxyapatite particles | Q44934395 |
| | Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant | Q44950022 |
| | In vitro and in vivo analysis of a biodegradable poly(lactide-co-glycolide) copolymer capsule and collagen composite system for antibiotics and bone cells delivery. | Q44953763 |
| | High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution | Q44986072 |
| | Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis | Q45093069 |
| | A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier | Q45173211 |
| | Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety | Q45324886 |
| | Anti-infection tissue engineering construct treating osteomyelitis in rabbit tibia | Q45367956 |
| | In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres. | Q45745627 |
| | Precipitation pattern formation in the copper(II) oxalate system with gravity flow and axial symmetry. | Q45944084 |
| | Shape and aggregation control of nanoparticles: not shaken, not stirred. | Q45953683 |
| | Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. | Q45958619 |
| | Gravity, a regulation factor in the differentiation of rat bone marrow mesenchymal stem cells | Q37368555 |
| | The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. | Q37429257 |
| | NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. | Q37475353 |
| | Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices | Q37634679 |
| | A tunable silk-alginate hydrogel scaffold for stem cell culture and transplantation | Q37677874 |
| | Amorphous calcium phosphates: synthesis, properties and uses in biomaterials | Q37694806 |
| | Skull-base osteomyelitis: fungal vs. bacterial infection. | Q37729271 |
| | Polymethylmethacrylate: properties and contemporary uses in orthopaedics. | Q37740788 |
| | Animal models for the study of osteomyelitis | Q37766773 |
| | Properties and applications of Zeolites | Q37806732 |
| | Nanosized hydroxyapatite and other calcium phosphates: Chemistry of formation and application as drug and gene delivery agents | Q37808165 |
| | Biodegradable antibiotic delivery systems | Q37833862 |
| | 'To bead or not to bead?' Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains | Q37872920 |
| | Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature | Q37880202 |
| | Theranostic nanoparticles engineered for clinic and pharmaceutics | Q37898091 |
| | Alveolar osteitis and osteomyelitis of the jaws | Q37907505 |
| | Chronic osteomyelitis following an uncomplicated dental extraction | Q37910338 |
| | Emerging pathogenetic mechanisms of the implant-related osteomyelitis by Staphylococcus aureus | Q37957607 |
| | Development of self-immolative dendrimers for drug delivery and sensing | Q37966587 |
| | Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety | Q37975404 |
| | Osteoporosis and trace elements--an overview | Q38009138 |
| | Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature | Q38009482 |
| | Antimicrobial options in the treatment of adult staphylococcal bone and joint infections in an era of drug shortages | Q38010326 |
| | Polymers and drug delivery systems | Q38013784 |
| | Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery | Q38015656 |
| | Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis | Q38028244 |
| | Recent development of small antimicrobial peptidomimetics. | Q38050179 |
| | The origins of antibiotic resistance | Q38054560 |
| | Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis | Q38071675 |
| | Dynamic Light Scattering Based Microelectrophoresis: Main Prospects and Limitations | Q38125672 |
| | Is bisphosphonate therapy compromised by the emergence of adverse bone disorders? | Q38131274 |
| | Delivery of antibiotics with polymeric particles. | Q38189164 |
| | Expression of core binding factor 1 and osteoblastic markers in C2C12 cells induced by calcium phosphate ceramics in vitro | Q38305190 |
| | Genetic profiling of osteoblast-like cells cultured on a novel bone reconstructive material, consisting of poly-L-lactide, carbon nanotubes and microhydroxyapatite, in the presence of bone morphogenetic protein-2. | Q38505861 |
| | In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants | Q38550389 |
| | Staphylococcus aureus fibronectin binding proteins are essential for internalization by osteoblasts but do not account for differences in intracellular levels of bacteria | Q24548694 |
| | Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β | Q24603082 |
| | Strongly bound citrate stabilizes the apatite nanocrystals in bone | Q24618644 |
| | Biomaterial delivery of morphogens to mimic the natural healing cascade in bone | Q26996479 |
| | Diagnosis and management of osteomyelitis | Q27009101 |
| | Safety issues with bisphosphonate therapy for osteoporosis | Q27026795 |
| | A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned | Q28242411 |
| | Challenges for the Modern Science in its Descend Towards Nano Scale | Q28610676 |
| | Self-setting calcium orthophosphate formulations | Q28659431 |
| | Entering the era of nanoscience: time to be so small. | Q28681114 |
| | Biomolecular coronas provide the biological identity of nanosized materials | Q29615557 |
| | Conformational Changes of Fibrinogen Adsorption onto Hydroxyapatite and Titanium Oxide Nanoparticles. | Q30322705 |
| | Formation of macropores in calcium phosphate cement implants | Q31109426 |
| | Antigenicity and immunogenicity of collagen | Q31114953 |
| | Nondecalcified histologic study of bone response to titanium implants topographically modified by laser with and without hydroxyapatite coating | Q31136493 |
| | Biological Apatite vs Hydroxyapatite at the Atomic Level | Q32072057 |
| | Osteomyelitis | Q33205211 |
| | Process and kinetics of bonelike apatite formation on sintered hydroxyapatite in a simulated body fluid | Q33211635 |
| | Adsorption and immobilization of cytochrome c on nanodiamonds. | Q33233144 |
| | Immunogenicity of unprocessed and photooxidized bovine and human osteochondral grafts in collagen-sensitive mice | Q33236890 |
| | Calcium phosphate cement: review of mechanical and biological properties | Q33256714 |
| | New hydroxyapatite monolithic column for DNA extraction and its application in the purification of Bacillus subtilis crude lysate | Q33318593 |
| | Bone formation on synthetic precursors of hydroxyapatite | Q33414920 |
| | A solid-state NMR study of lead and vanadium substitution into hydroxyapatite | Q33421482 |
| | Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement | Q33436094 |
| | A clinical and histological case series study on calcium sulfate for maxillary sinus floor augmentation and delayed placement of dental implants | Q33511519 |
| | In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis | Q33558927 |
| | Mechanical characterization of biodegradable implants | Q33577214 |
| | The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized rats | Q33676404 |
| | In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis | Q33709398 |
| | Characterization of the chemically deposited hydroxyapatite coating on a titanium substrate. | Q33739270 |
| | Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. | Q33748933 |
| | Clinical practice. Infection associated with prosthetic joints | Q33771840 |
| | Antibiotic beads in the treatment of diabetic pedal osteomyelitis | Q33902716 |
| | Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid. | Q50968877 |
| | Formulation, characterization and pharmacokinetic evaluation of gentamicin sulphate loaded albumin microspheres. | Q51036867 |
| | In vivo evaluation of an injectable Macroporous Calcium Phosphate Cement. | Q51061154 |
| | Staphylococcus aureus adhesion to standard micro-rough and electropolished implant materials. | Q51075989 |
| | Tissue reactions to bioabsorbable ciprofloxacin-releasing polylactide-polyglycolide 80/20 screws in rabbits' cranial bone. | Q51098209 |
| | Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects. | Q51132021 |
| | Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles. | Q51185404 |
| | Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. | Q51223081 |
| | The structure of the bond between bone and porous silicon-substituted hydroxyapatite bioceramic implants. | Q51233245 |
| | Dietary coral calcium and zeolite protects bone in a mouse model for postmenopausal bone loss. | Q51287903 |
| | Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study. | Q51291195 |
| | Anorganic bovine-derived hydroxyapatite versus β-tricalcium phosphate in sinus augmentation. A comparative histomorphometric study. | Q51338223 |
| | Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. | Q51391071 |
| | Nanoporous delivery system to treat osteomyelitis and regenerate bone: gentamicin release kinetics and bactericidal effect. | Q51548301 |
| | Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design". | Q51591631 |
| | Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an alpha-TCP paste. | Q51701761 |
| | Encapsulation of Cwp84 into pectin beads for oral vaccination against Clostridium difficile. | Q51764937 |
| | Characterization of a novel calcium phosphate/sulphate bone cement. | Q52036828 |
| | A combined approach for treatment of developmental groove associated periodontal defect. A case report. | Q52186928 |
| | Estimation of ideal mechanical strength and critical porosity of calcium phosphate cement. | Q52322379 |
| | Space-cutting model of hydroxyapatite. | Q52360133 |
| | Calcium phosphate scaffolds mimicking the gradient architecture of native long bones. | Q53086654 |
| | Probing oxygen vacancy concentration and homogeneity in solid-oxide fuel-cell cathode materials on the subunit-cell level. | Q53150558 |
| | Statistical analysis of variation in laboratory growth of carbon nanotube forests and recommendations for improved consistency. | Q53338634 |
| | Templated synthesis of amphiphilic nanoparticles at the liquid-liquid interface. | Q53392547 |
| | [A new method for the removal of chronic bone suppuration. Report on the removal of osteomyelitic and multi-infected tuberculous fistulae by filling the bone cavity with polyamide fibers] | Q53803408 |
| | Osteolytic changes accompanying degradation of absorbable fracture fixation implants | Q54076896 |
| | Influence of the zeta potential on the sorption and toxicity of iron oxide nanoparticles on S. cerevisiae and E. coli. | Q54387675 |
| | Ofloxacin-delivery system of a polyanhydride and polylactide blend used in the treatment of bone infection. | Q54443727 |
| | Monoolein-water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization | Q56497824 |
| | A novel route in bone tissue engineering: magnetic biomimetic scaffolds | Q56988985 |
| | Evaluation of sericin/collagen membranes as prospective wound dressing biomaterial | Q57218486 |
| | Silk coating on poly(ε-caprolactone) microspheres for the delayed release of vancomycin | Q57218823 |
| | Injectable calcium phosphate cement with PLGA, gelatin and PTMC microspheres in a rabbit femoral defect | Q57219840 |
| | Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites | Q57224396 |
| | Properties of heterogeneous apatites containing magnesium, fluoride, and carbonate | Q57224834 |
| | Mechanical and bone ingrowth properties of a polymer-coated, porous, synthetic, coralline hydroxyapatite bone-graft material | Q57227256 |
| | Assessment of the suitability of a new brushite calcium phosphate cement for cranioplasty – an experimental study in sheep | Q58482612 |
| | II. On the Present State of Knowledge in Bacterial Science in Its Surgical Relations (Continued): Osteomyelitis | Q58732555 |
| | Covalent Incorporation of Aminated Nanodiamond into an Epoxy Polymer Network | Q58892725 |
| | Magnesium- and strontium-co-substituted hydroxyapatite: the effects of doped-ions on the structure and chemico-physical properties | Q60435278 |
| | Influence of the pore generator on the evolution of the mechanical properties and the porosity and interconnectivity of a calcium phosphate cement | Q61827086 |
| | Compositional changes of a dicalcium phosphate dihydrate cement after implantation in sheep | Q61827161 |
| | Gentamicin-Loaded Hydraulic Calcium Phosphate Bone Cement as Antibiotic Delivery System | Q61827179 |
| | Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour | Q62271168 |
| | Degradative behaviour of polymeric matrices in (sub)dermal and muscle tissue of the rat: a quantitative study | Q63989217 |
| | Gentamicin-collagen sponge for local applications: 10 cases of chronic osteomyelitis followed for 1 year | Q67818546 |
| | In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads | Q67904950 |
| | Preparation and characterization of indomethacin magnetic nanoparticles | Q67981772 |
| | In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads | Q68095133 |
| | Diagnosis and treatment of pyogenic bone infections | Q33956127 |
| | Carrier systems for the local delivery of antibiotics in bone infections | Q33959095 |
| | Quantum dot conjugated hydroxylapatite nanoparticles for in vivo imaging | Q33985724 |
| | The effectiveness of the controlled release of gentamicin from polyelectrolyte multilayers in the treatment of Staphylococcus aureus infection in a rabbit bone model | Q34032557 |
| | Encapsulation of plasmid DNA in calcium phosphate nanoparticles: stem cell uptake and gene transfer efficiency | Q34121750 |
| | Antimicrobial applications of nanotechnology: methods and literature | Q34284938 |
| | Antimicrobial biocompatible bioscaffolds for orthopaedic implants | Q34304688 |
| | Doped quantum dots for chemo/biosensing and bioimaging | Q34335057 |
| | Novel selenium-doped hydroxyapatite coatings for biomedical applications. | Q34411749 |
| | Multifunctional hydroxyapatite and poly(D,L-lactide-co-glycolide) nanoparticles for the local delivery of cholecalciferol | Q34454120 |
| | How useful is SBF in predicting in vivo bone bioactivity? | Q34489970 |
| | Magnetic poly(ε-caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering. | Q34543166 |
| | Scanning electron microscopy-based approach to understand the mechanism underlying the adhesion of dengue viruses on ceramic hydroxyapatite columns | Q34551890 |
| | Nonallograft osteoconductive bone graft substitutes | Q34591364 |
| | Buruli ulcer (Mycobacterium ulcerans infection). | Q34594767 |
| | Characterization of Osterix protein stability and physiological role in osteoblast differentiation | Q34606834 |
| | The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder | Q34692277 |
| | In Vitro and in Vivo Characteristics of Fluorapatite-Forming Calcium Phosphate Cements | Q34772398 |
| | Adhesion between biodegradable polymers and hydroxyapatite: Relevance to synthetic bone-like materials and tissue engineering scaffolds | Q34779130 |
| | Magnesium metabolism in 4-year-old to 8-year-old children | Q34779875 |
| | Polyanhydride implant for antibiotic delivery--from the bench to the clinic | Q34971419 |
| | Collagen as an implantable material in medicine and dentistry | Q35033111 |
| | Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells | Q35070404 |
| | Infection and tissue engineering in segmental bone defects--a mini review. | Q35112552 |
| | Cooperative macromolecular self-assembly toward polymeric assemblies with multiple and bioactive functions. | Q35138118 |
| | Bone as an effect compartment : models for uptake and release of drugs. | Q35186641 |
| | BMP-2 gene-fibronectin-apatite composite layer enhances bone formation | Q35219496 |
| | Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection. | Q35574932 |
| | Enhanced affinity bifunctional bisphosphonates for targeted delivery of therapeutic agents to bone | Q35637157 |
| | Bone: from a reservoir of minerals to a regulator of energy metabolism | Q35669357 |
| | Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. | Q35954867 |
| | Poly(propylene fumarate) reinforced dicalcium phosphate dihydrate cement composites for bone tissue engineering | Q35989677 |
| | Soft fibrin gels promote selection and growth of tumorigenic cells. | Q36117097 |
| | Tissue engineering strategies for bone regeneration. | Q36138759 |
| | Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping | Q36197637 |
| | Biomechanical characterization of a biodegradable calcium phosphate hydraulic cement: a comparison with porous biphasic calcium phosphate ceramics | Q38552963 |
| | Osteoinductive potential of freeze-dried, biodegradable, poly (glycolic acid-co-lactic acid) disks incorporated with bone morphogenetic protein in skull defects of rats | Q38560166 |
| | Hydroxylapatite nanoparticles: fabrication methods and medical applications | Q39017420 |
| | The effect of ethylene oxide sterilization on the surface chemistry and in vitro cytotoxicity of several kinds of chitosan | Q39018891 |
| | Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus | Q39019951 |
| | Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection | Q39037822 |
| | Factors affecting the solubility of calcium pyrophosphate dihydrate crystals | Q39064326 |
| | Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics | Q39086016 |
| | Composite PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive, antioxidative, and antimicrobial activities | Q39103790 |
| | Osteogenic and antimicrobial nanoparticulate calcium phosphate and poly-(D,L-lactide-co-glycolide) powders for the treatment of osteomyelitis. | Q39147816 |
| | Nanomaterials enhance osteogenic differentiation of human mesenchymal stem cells similar to a short peptide of BMP-7. | Q39177025 |
| | In vitro osteoclast-like and osteoblast cells' response to electrospun calcium phosphate biphasic candidate scaffolds for bone tissue engineering | Q39281645 |
| | Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. | Q39282521 |
| | Enhanced gene transfection using calcium phosphate co-precipitates and low-intensity pulsed ultrasound | Q39291426 |
| | Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis | Q39335755 |
| | Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface | Q39356978 |
| | Serum albumin enhances bone healing in a nonunion femoral defect model in rats: a computer tomography micromorphometry study | Q39363095 |
| | The biocompatibility of metal-organic framework coatings: an investigation on the stability of SURMOFs with regard to water and selected cell culture media | Q39370212 |
| | Toxicity and genotoxicity of nano-SiO2 on human epithelial intestinal HT-29 cell line. | Q39387869 |
| | Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release | Q39399766 |
| | Nanohydroxyapatite increases BMP-2 expression via a p38 MAP kinase dependent pathway in periodontal ligament cells | Q39447263 |
| | Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines | Q39456119 |
| | Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin. | Q39544770 |
| | Physiology of hard tissues in comparison with the solubility of synthetic calcium phosphates | Q39647095 |
| | Antimicrobial and osteogenic properties of a hydrophilic-modified nanoscale hydroxyapatite coating on titanium | Q39725740 |
| | Bacterially induced bone destruction: mechanisms and misconceptions. | Q39825282 |
| | Differentiation of activated monocytes into osteoclast-like cells on a hydroxyapatite substrate: an in vitro study. | Q39850389 |
| | Long-term small molecule and protein elution from TiO2 nanotubes | Q39867967 |
| | Osteomyelitis: A Review of Clinical Features, Therapeutic Considerations and Unusual Aspects | Q39986155 |
| | Surfactant-free, drug-quantum-dot coloaded poly(lactide-co-glycolide) nanoparticles: towards multifunctional nanoparticles | Q40003796 |
| | Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. | Q40094469 |
| | Effect of rapidly resorbable bone substitute materials on the temporal expression of the osteoblastic phenotype in vitro | Q40106546 |
| | Vanadyl(IV) complexes with saccharides. Bioactivity in osteoblast-like cells in culture | Q40228119 |
| | Substitution of osteoporotic alveolar bone by biphasic calcium phosphate/poly-DL-lactide-co-glycolide biomaterials. | Q40251012 |
| | Chronic staphylococcal osteomyelitis: a new experimental rat model | Q40269861 |
| | Osteomyelitis variolosa: a case report | Q40327023 |
| | Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections | Q40483507 |
| | Basic fibroblast growth factor adsorption and release properties of calcium phosphate | Q40851732 |
| | Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. | Q40921824 |
| | Local antibiotic therapy in osteomyelitis | Q41034784 |
| | Staphylococcus aureus invasion of bovine mammary epithelial cells | Q41193575 |
| | Hydroxyapatite nanoparticles as particulate emulsifier: fabrication of hydroxyapatite-coated biodegradable microspheres. | Q45974804 |
| | In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. | Q46037645 |
| | Simultaneous incorporation of carbonate and fluoride in synthetic apatites: Effect on crystallographic and physico-chemical properties | Q46096348 |
| | The effect of extracellular calcium and inorganic phosphate on the growth and osteogenic differentiation of mesenchymal stem cells in vitro: implication for bone tissue engineering | Q46125813 |
| | Effects of bead size and polymerization in PMMA bone cement on vancomycin release | Q46131516 |
| | Solubility of strontium-substituted apatite by solid titration | Q46168560 |
| | Proceedings: Silicon as an essential element | Q46281974 |
| | Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis | Q46285888 |
| | High-strength resorbable brushite bone cement with controlled drug-releasing capabilities. | Q46361536 |
| | Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. | Q46420339 |
| | Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats | Q46466899 |
| | Biocompatibility of a polymeric implant for the treatment of osteomyelitis. | Q46481981 |
| | Physico-chemical characteristics and protein adsorption potential of hydroxyapatite particles: influence on in vitro biocompatibility of ceramics after sintering. | Q46490248 |
| | In vitro evaluation of a fibrin gel antibiotic delivery system containing mesenchymal stem cells and vancomycin alginate beads for treating bone infections and facilitating bone formation. | Q46507949 |
| | Persistence of bacterial growth on antibiotic-loaded beads: is it actually a problem? | Q46592555 |
| | Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant | Q46592560 |
| | Production of in-situ macropores in an injectable calcium phosphate cement by introduction of cetyltrimethyl ammonium bromide. | Q46615429 |
| | Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study | Q46729311 |
| | Preparation, physical-chemical characterisation and cytocompatibility of calcium carbonate cements | Q46747638 |
| | Synthesis and swelling properties of novel pH-sensitive poly(aspartic acid) gels | Q46748951 |
| | Silica nanoparticles administered at the maximum tolerated dose induce genotoxic effects through an inflammatory reaction while gold nanoparticles do not. | Q46757299 |
| | Insights into morphological nature of precipitation of cholesterol | Q46794475 |
| | Preliminary investigations on a new gentamicin and vancomycin-coated PMMA nail for the treatment of bone and intramedullary infections: An experimental study in the rabbit | Q46814993 |
| | Biocompatibility and effect on osteogenesis of poly(ortho ester) compared to poly(DL-lactic acid). | Q46830407 |
| | Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis | Q46881245 |
| | Compaction strategies for modifying the drug delivery capabilities of gelled calcium polyphosphate matrices | Q46904020 |
| | The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model | Q46910026 |
| | Composites comprising cholesterol and carboxymethyl cellulose | Q46939900 |
| | Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals construction | Q46962692 |
| | Degradation behavior of hydrophilized PLGA scaffolds prepared by melt-molding particulate-leaching method: comparison with control hydrophobic one. | Q46963799 |
| | Cation control of pore and channel size in cage-based metal-organic porous materials | Q47192762 |
| | Shape and size of isolated bone mineralites measured using atomic force microscopy | Q47195485 |
| | Effect of sterilisation by gamma irradiation on the ability of polycaprolactone (PCL) to act as a scaffold material | Q47372145 |
| | Albumin/gentamicin microspheres produced by supercritical assisted atomization: optimization of size, drug loading and release. | Q47414417 |
| | Size effect of calcium phosphate coated with poly-DL-lactide- co-glycolide on healing processes in bone reconstruction. | Q47429538 |
| | Actinomycotic osteomyelitis of the facial bones and mandible | Q47609904 |
| | In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers | Q47659662 |
| | Signaling responses of osteoblast cells to hydroxyapatite: the activation of ERK and SOX9. | Q47886994 |
| | Bone regenerative properties of injectable PGLA-CaP composite with TGF-beta1 in a rat augmentation model. | Q47921909 |
| | Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow-derived stromal cells | Q47953342 |
| | Introduction of gelatin microspheres into an injectable calcium phosphate cement | Q47981064 |
| | Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes | Q48168635 |
| | Stimulation of cell proliferation by calcium and a calcimimetic compound | Q48632470 |
| | Effects of four types of hydroxyapatite nanoparticles with different nanocrystal morphologies and sizes on apoptosis in rat osteoblasts | Q50263241 |
| | Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions | Q50447199 |
| | Calcium phosphate-mediated gene delivery using simulated body fluid (SBF). | Q50495786 |
| | An evaluation of plaster of Paris barriers used under various materials to repair furcation perforations (in vitro study). | Q50516183 |
| | Magnesium, zinc, copper, manganese, and selenium levels in postmenopausal women with osteoporosis. Can magnesium play a key role in osteoporosis? | Q50638668 |
| | Intrinsic magnetism and hyperthermia in bioactive Fe-doped hydroxyapatite. | Q50790509 |
| | Preparation of porous apatite granules from calcium phosphate cement. | Q50852997 |
| | Polylactide-polyglycolide antibiotic implants | Q36213851 |
| | Intrinsically superparamagnetic Fe-hydroxyapatite nanoparticles positively influence osteoblast-like cell behaviour | Q36281568 |
| | Effect of silver content on the structure and antibacterial activity of silver-doped phosphate-based glasses. | Q36313255 |
| | Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. | Q36407629 |
| | The circadian clock modulates enamel development | Q36438704 |
| | Antimicrobial peptides: review of their application in musculoskeletal infections | Q36465051 |
| | Nanoparticles of cobalt-substituted hydroxyapatite in regeneration of mandibular osteoporotic bones | Q36597932 |
| | Hydroxyapatite nanoparticle-containing scaffolds for the study of breast cancer bone metastasis | Q36731717 |
| | Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures | Q36732299 |
| | Bone crystal sizes: a comparison of transmission electron microscopic and X-ray diffraction line width broadening techniques | Q36735082 |
| | Effect of calcium phosphate particle shape and size on their antibacterial and osteogenic activity in the delivery of antibiotics in vitro. | Q36826117 |
| | The tumor microenvironment is a dominant force in multidrug resistance. | Q36856829 |
| | Design Strategies for Fluorescent Biodegradable Polymeric Biomaterials | Q36864841 |
| | Collagen: finding a solution for the source | Q36880083 |
| | Osteoblast and osteoclast differentiation in modeled microgravity | Q36893362 |
| | Human bites in the classroom: incidence, treatment, and complications | Q36901794 |
| | Osteoporosis - a current view of pharmacological prevention and treatment | Q36939677 |
| | Mesoporous materials for drug delivery. | Q36939951 |
| | Radially branched deployment for more efficient cell transplantation at the scale of the human brain. | Q37086202 |
| | Citrate-based Biodegradable Injectable hydrogel Composites for Orthopedic Applications | Q37109770 |
| | Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). | Q37126334 |
| | Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature | Q37149727 |
| | Mini-review: Proactive biomaterials and bone tissue engineering | Q37216521 |
| | Development of aliphatic biodegradable photoluminescent polymers. | Q37238799 |
| | The Important Role of Osteoblasts and Citrate Production in Bone Formation: "Osteoblast Citration" as a New Concept for an Old Relationship | Q37274467 |
| | SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo | Q37301787 |
| | Calcium sulfate: Properties and clinical applications | Q37331920 |
| | Osteopontin functionalization of hydroxyapatite nanoparticles in a PDLLA matrix promotes bone formation. | Q41222986 |
| | Bioelectric potential gradients may initiate cell cycling: ELF and zeta potential gradients may mimic this effect | Q41519426 |
| | In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(epsilon-caprolactone) microparticles | Q41816207 |
| | Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery | Q41847599 |
| | A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis | Q41864671 |
| | Effect of hydroxyapatite on the physicochemical characteristics of a gentamicin-loaded monoolein gel intended to treat chronic osteomyelitis | Q41931511 |
| | The drug release study of ceftriaxone from porous hydroxyapatite scaffolds | Q41989195 |
| | A new antibacterial carrier of hyaluronic acid gel. | Q42034233 |
| | In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods | Q42169329 |
| | Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy | Q42265900 |
| | Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes | Q42622238 |
| | A new, simple, green, and one-pot four-component synthesis of bare and poly(α,γ, L-glutamic acid)-capped silver nanoparticles | Q42648217 |
| | Toxicogenomic analysis of the particle dose- and size-response relationship of silica particles-induced toxicity in mice. | Q42713878 |
| | Brucella osteomyelitis of the proximal tibia: a case report | Q42752200 |
| | Nano-sized calcium phosphate particles for periodontal gene therapy | Q42798305 |
| | Osteoblast activity on carbonated hydroxyapatite | Q42799854 |
| | Sol-gel processed mupirocin silica microspheres loaded collagen scaffold: a synergistic bio-composite for wound healing | Q42806937 |
| | Reduction of inflammatory reaction of poly(d,l-lactic-co-glycolic Acid) using demineralized bone particles | Q42815499 |
| | Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. II. Antibacterial and osteoblastic response | Q42829153 |
| | A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion | Q42958962 |
| | Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model | Q43077573 |
| | Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity | Q43080159 |
| | Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles. | Q43104462 |
| | Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts*1 | Q68325243 |
| | Rapid release of gentamicin from collagen sponge. In vitro comparison with plastic beads | Q68924484 |
| | Biomaterial-centered infection: microbial adhesion versus tissue integration | Q69249483 |
| | Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis | Q70490112 |
| | In vivo assessment of methyl methacrylate metabolism and toxicity | Q70952032 |
| | Osteo-articular complications of smallpox vaccination | Q71579554 |
| | Depot effects of various antibiotics mixed with Palacos resins | Q71612918 |
| | A self-setting TTCP-DCPD apatite cement for release of vancomycin | Q71670511 |
| | Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement | Q71952564 |
| | Zeolite a inhibits osteoclast‐mediated bone resorption in vitro | Q71977669 |
| | Elution characteristics of gentamicin-PMMA beads after implantation in humans | Q72072348 |
| | The effect of site of implantation and animal age on properties of polydioxanone pins | Q72496636 |
| | Polymeric calcium phosphate cements: setting reaction modifiers | Q72753949 |
| | Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production | Q73175508 |
| | Enhanced osteoclast-like cell functions on nanophase ceramics | Q73834400 |
| | Calcium hydroxide ameliorates tobramycin toxicity in cultured chick tibiae | Q73843941 |
| | Enhanced functions of osteoblasts on nanophase ceramics | Q74033988 |
| | Comparison of different types of ceramic hydroxyapatite for the chromatographic separation of plasmid DNA and a recombinant anti-rhesus D antibody | Q74414236 |
| | Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing | Q74777183 |
| | [Mechanical failure of porous hydroxyapatite ceramics 7.5 years after implantation in the proximal tibial] | Q76402766 |
| | Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block | Q77052383 |
| | Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms | Q77364480 |
| | Chemical characterization of silicon-substituted hydroxyapatite | Q77975538 |
| | Raman microspectrometry studies of brushite cement: in vivo evolution in a sheep model | Q78160950 |
| | What is the normal rate of bone remodeling? | Q80222494 |
| | Locally administered antibiotics for prophylaxis against surgical wound infection. An in vivo study | Q80249232 |
| | Performance and characterization of a nanophased porous hydroxyapatite for protein chromatography | Q80389880 |
| | Use of calcium-based demineralized bone matrix/allograft for nonunions and posttraumatic reconstruction of the appendicular skeleton: preliminary results and complications | Q80532738 |
| | Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices | Q80681988 |
| | High-strength apatitic cement by modification with superplasticizers | Q81109856 |
| | Importance of the surface area ratio on cytokines production by human monocytes in vitro induced by various hydroxyapatite particles | Q81109867 |
| | Improved antibody aggregate removal by hydroxyapatite chromatography in the presence of polyethylene glycol | Q81503065 |
| | In vivo performance of two different hydroxyapatite coatings on titanium prepared by discharging in electrolytes | Q81641368 |
| | Formation of cadmium sulfide nanoparticles in reverse micelles: extreme sensitivity to preparation procedure | Q81905593 |
| | Development of gentamicin resistance after gentamicin-PMMA beads for treatment of foot osteomyelitis: report of two cases | Q82158126 |
| | BMP-2/PLGA delayed-release microspheres composite graft, selection of bone particulate diameters, and prevention of aseptic inflammation for bone tissue engineering | Q82398514 |
| | Evaluation of in vitro serial antibiotic elution from meropenem-impregnated polymethylmethacrylate beads after ethylene oxide gas and autoclave sterilization | Q82584910 |
| | Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion | Q82629527 |
| | Functionalized bridged silsesquioxane-based nanostructured microspheres: performance as novel drug-delivery devices in bone tissue-related applications | Q82694721 |
| | Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits | Q82902262 |
| | Calcium sulfates: what is the evidence? | Q83024331 |
| | Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections | Q83095030 |
| | Macro-to-micro porous special bioactive glass and ceftriaxone-sulbactam composite drug delivery system for treatment of chronic osteomyelitis: an investigation through in vitro and in vivo animal trial | Q83164051 |
| | Injectable and macroporous calcium phosphate cement scaffold | Q83227776 |
| | Gentamicin serum concentrations in patients with gentamicin-PMMA beads for infected hip joints: a prospective observational cohort study | Q83254428 |
| | Scavenging ROS: superoxide dismutase/catalase mimetics by the use of an oxidation-sensitive nanocarrier/enzyme conjugate | Q83367321 |
| | Rapid resorption of calcium sulfate and hardware failure following corrective radius osteotomy: 2 case reports | Q83392452 |
| | Tunable metallicity of the La5/8Ca3/8MnO3(001) surface by an oxygen overlayer | Q83419923 |
| | A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins | Q83459464 |
| | Segmental bone regeneration using rhBMP-2-loaded collagen/chitosan microspheres composite scaffold in a rabbit model | Q83497500 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteomyelitis | Q938983 |
| P304 | page(s) | 1-59 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Critical Reviews in Therapeutic Drug Carrier Systems | Q15761680 |
| P1476 | title | Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis | |
| P478 | volume | 32 | |